{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:46:29Z","timestamp":1790685989895,"version":"4.1.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s11845-022-02998-9","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T11:05:23Z","timestamp":1649415923000},"page":"231-261","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Toxoplasma gondii vaccine candidates: a concise review"],"prefix":"10.1007","volume":"192","author":[{"given":"Amirreza Javadi","family":"Mamaghani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar","family":"Fathollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Arab-Mazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kobra","family":"kohansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matin","family":"Fathollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Spotin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homayoon","family":"Bashiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezoo","family":"Bozorgomid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,8]]},"reference":[{"issue":"1","key":"2998_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4103\/1995-7645.223562","volume":"11","author":"N Nazari","year":"2018","unstructured":"Nazari N, Bozorgomid A, Janbakhsh A, Bashiri F (2018) Toxoplasma gondii and human immunodeficiency virus co-infection in western Iran: a cross sectional study. Asian Pac J Trop Med 11(1):58","journal-title":"Asian Pac J Trop Med"},{"key":"2998_CR2","first-page":"2845","volume":"10","author":"E Gilot-Fromont","year":"2012","unstructured":"Gilot-Fromont E, L\u00e9lu M, Dard\u00e9 M-L et al (2012) The life cycle of Toxoplasma gondii in the natural environment. Toxoplasmosis-recent advances 10:2845","journal-title":"Toxoplasmosis-recent advances"},{"key":"2998_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/b978-0-444-53490-3.00008-x","volume":"114","author":"SK Halonen","year":"2013","unstructured":"Halonen SK, Weiss LM (2013) Toxoplasmosis Handbook of clinical neurology 114:125\u2013145. https:\/\/doi.org\/10.1016\/b978-0-444-53490-3.00008-x","journal-title":"Toxoplasmosis Handbook of clinical neurology"},{"issue":"3","key":"2998_CR4","first-page":"745","volume":"33","author":"VB Carruthers","year":"2007","unstructured":"Carruthers VB, Suzuki Y (2007) Effects of Toxoplasma gondii infection on the brain 33(3):745\u2013751","journal-title":"Effects of Toxoplasma gondii infection on the brain"},{"issue":"1","key":"2998_CR5","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1128\/iai.05899-11","volume":"80","author":"JR Robbins","year":"2012","unstructured":"Robbins JR, Zeldovich VB, Poukchanski A et al (2012) Tissue barriers of the human placenta to infection with Toxoplasma gondii. Infect Immun 80(1):418\u2013428. https:\/\/doi.org\/10.1128\/iai.05899-11","journal-title":"Infect Immun"},{"key":"2998_CR6","doi-asserted-by":"crossref","unstructured":"Javadi Mamaghani, A, Tabaei SJS, Ranjbar MM et al (2020) Designing diagnostic kit for Toxoplasma gondii based on GRA7, SAG1, and ROP1 Antigens: an in silico strategy. Int J Peptide Res Therapeutics 26(4):2269\u20132283","DOI":"10.1007\/s10989-020-10021-x"},{"key":"2998_CR7","doi-asserted-by":"crossref","unstructured":"Stelzer S, Basso W, Silv\u00e1n JB et al (2019) Toxoplasma gondii infection and toxoplasmosis in farm animals: risk factors and economic impact.\u00a0Food Waterborne Parasitol\u00a015:e00037","DOI":"10.1016\/j.fawpar.2019.e00037"},{"key":"2998_CR8","doi-asserted-by":"crossref","unstructured":"Konstantinovic N, Guegan H, St\u00e4jner T et al (2019) Treatment of toxoplasmosis: current options and future perspectives.\u00a0Food Waterborne Parasitol\u00a015","DOI":"10.1016\/j.fawpar.2019.e00036"},{"issue":"2","key":"2998_CR9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1128\/cmr.05013-11","volume":"25","author":"F Robert-Gangneux","year":"2012","unstructured":"Robert-Gangneux F, Dard\u00e9 ML (2012) Epidemiology of and diagnostic strategies for toxoplasmosis.\u00a0Clin Microbiol Rev\u00a025(2):264\u2013296. https:\/\/doi.org\/10.1128\/cmr.05013-11","journal-title":"Clinical microbiology reviews Clinical microbiology reviews"},{"key":"2998_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/dddt.S60973","volume":"11","author":"PH Alday","year":"2017","unstructured":"Alday PH, Doggett JS (2017) Drugs in development for toxoplasmosis: advances, challenges, and current status. Drug Des Dev Ther 11:273\u2013293. https:\/\/doi.org\/10.2147\/dddt.S60973","journal-title":"Drug Des Dev Ther"},{"issue":"10","key":"2998_CR11","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1007\/s00436-018-6027-z","volume":"117","author":"M Montazeri","year":"2018","unstructured":"Montazeri M, Mehrzadi S, Sharif M et al (2018) Activities of anti-Toxoplasma drugs and compounds against tissue cysts in the last three decades (1987 to 2017), a systematic review. Parasitol Res 117(10):3045\u20133057. https:\/\/doi.org\/10.1007\/s00436-018-6027-z","journal-title":"Parasitol Res"},{"issue":"2","key":"2998_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1128\/CMR.11.2.267","volume":"11","author":"JP Dubey","year":"1998","unstructured":"Dubey JP, Lindsay DS, Speer CA (1998) Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin Microbiol Rev 11(2):267\u2013299","journal-title":"Clin Microbiol Rev"},{"key":"2998_CR13","doi-asserted-by":"publisher","unstructured":"Black MW, Boothroyd JC (2000) Lytic cycle of Toxoplasma gondii. Microbiology and molecular biology reviews. Microbiol Mol Biol Rev 64(3):607\u2013623.\u00a0https:\/\/doi.org\/10.1128\/mmbr.64.3.607-623.2000","DOI":"10.1128\/mmbr.64.3.607-623.2000"},{"issue":"1","key":"2998_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41426-018-0164-4","volume":"7","author":"K El Bissati","year":"2018","unstructured":"El Bissati K, Levigne P, Lykins J et al (2018) Global initiative for congenital toxoplasmosis: an observational and international comparative clinical analysis.\u00a0Emerg Microbes & Infect\u00a07(1):165. https:\/\/doi.org\/10.1038\/s41426-018-0164-4","journal-title":"Emerging microbes & infections"},{"key":"2998_CR15","doi-asserted-by":"publisher","unstructured":"Flegr J, Prandota J, Sovi\u010dkov\u00e1 M, Israili ZH (2014) Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PloS one 9(3):e90203. https:\/\/doi.org\/10.1371\/journal.pone.0090203","DOI":"10.1371\/journal.pone.0090203"},{"issue":"1","key":"2998_CR16","first-page":"39","volume":"13","author":"MT Ahady","year":"2018","unstructured":"Ahady MT, Hoghooghi-Rad N, Madani R, Esmaeili Rastaghi AR (2018) Identification of Antigenic and immunogenic proteins of Toxoplasma gondii in human and sheep by immunoproteomics. Iran J Parasitol 13(1):39\u201348","journal-title":"Iran J Parasitol"},{"issue":"8","key":"2998_CR17","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3390\/ani10081245","volume":"10","author":"B Ferra","year":"2020","unstructured":"Ferra B, Holec-G\u0105sior L, Gr\u0105\u017alewska W (2020) Toxoplasma gondii recombinant antigens in the serodiagnosis of toxoplasmosis in domestic and farm animals. Animals 10(8):1245. https:\/\/doi.org\/10.3390\/ani10081245","journal-title":"Animals"},{"issue":"2","key":"2998_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1089\/mab.2019.0041","volume":"39","author":"M Naghi Vishteh","year":"2020","unstructured":"Naghi Vishteh M, Javadi Mamaghani A, Rashidi S et al (2020) Peptide-based monoclonal antibody production against SAG1 (P30) protein of Toxoplasma gondii. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 39(2):51\u201356","journal-title":"Monoclonal Antibodies in Immunodiagnosis and Immunotherapy"},{"issue":"8","key":"2998_CR19","doi-asserted-by":"publisher","first-page":"901","DOI":"10.22038\/ijbms.2019.34872.8276","volume":"22","author":"F Ghaffarifar","year":"2019","unstructured":"Ghaffarifar F, Jafarimodrek M, Vazini H et al (2019) Assessment of DNA vaccine encoding Toxoplasma gondii microneme complete gene and IL-12 as adjuvant in BALB\/c mice. Iran J Basic Med Sci 22(8):901\u2013907. https:\/\/doi.org\/10.22038\/ijbms.2019.34872.8276","journal-title":"Iran J Basic Med Sci"},{"key":"2998_CR20","doi-asserted-by":"crossref","unstructured":"Javadi Mamaghani, A, Fathollahi A, Spotin A (2019) Candidate antigenic epitopes for vaccination and diagnosis strategies of Toxoplasma gondii infection: a review.\u00a0Microb Pathog\u00a0137:103788","DOI":"10.1016\/j.micpath.2019.103788"},{"issue":"51","key":"2998_CR21","doi-asserted-by":"publisher","first-page":"88351","DOI":"10.18632\/oncotarget.19362","volume":"8","author":"S Wang","year":"2017","unstructured":"Wang S, Zhang Z, Wang Y et al (2017) Toxoplasma gondii excretory\/secretory antigens (TgESAs) suppress pro-inflammatory cytokine secretion by inhibiting TLR-induced NF-\u03baB activation in LPS-stimulated murine macrophages. Oncotarget 8(51):88351\u201388359. https:\/\/doi.org\/10.18632\/oncotarget.19362","journal-title":"Oncotarget"},{"issue":"13","key":"2998_CR22","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1017\/S0031182019001033","volume":"146","author":"Z Arab-Mazar","year":"2019","unstructured":"Arab-Mazar Z, Fallahi S, Yadegarynia D, Javadi Mamaghani A et al (2019) Immunodiagnosis and molecular validation of Toxoplasma gondii infection among patients with end-stage renal disease undergoing haemodialysis. Parasitology 146(13):1683\u20131689","journal-title":"Parasitology"},{"issue":"12","key":"2998_CR23","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0020-7519(01)00257-0","volume":"31","author":"D Soldati","year":"2001","unstructured":"Soldati D, Dubremetz JF, Lebrun M (2001) Microneme proteins: structural and functional requirements to promote adhesion and invasion by the apicomplexan parasite Toxoplasma gondii. Int J Parasitol 31(12):1293\u20131302","journal-title":"Int J Parasitol"},{"issue":"2","key":"2998_CR24","first-page":"220","volume":"22","author":"A Daryani","year":"2013","unstructured":"Daryani A, Kalani H, Sharif M et al (2013) Toxoplasma gondii: a review of excretory secretory antigens. J Mazandaran University of Medical Sci 22(2):220\u2013232","journal-title":"J Mazandaran University of Medical Sci"},{"key":"2998_CR25","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fcimb.2019.00136","volume":"9","author":"IA Khan","year":"2019","unstructured":"Khan IA, Hwang S, Moretto M (2019) Toxoplasma gondii: CD8 T Cells Cry for CD4 Help. Front Cell Infect Microbiol 9:136. https:\/\/doi.org\/10.3389\/fcimb.2019.00136","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"2998_CR26","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1128\/CMR.11.4.569","volume":"11","author":"EY Denkers","year":"1998","unstructured":"Denkers EY, Gazzinelli RT (1998) Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 11(4):569\u2013588","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"2998_CR27","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00281-012-0339-3","volume":"34","author":"CD Dupont","year":"2012","unstructured":"Dupont CD, Christian DA, Hunter CA (2012) Immune response and immunopathology during toxoplasmosis.\u00a0Semin Immunopathol\u00a034(6):793\u2013813. https:\/\/doi.org\/10.1007\/s00281-012-0339-3","journal-title":"Seminars in immunopathology"},{"issue":"9","key":"2998_CR28","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.4161\/hv.21006","volume":"8","author":"Q Liu","year":"2012","unstructured":"Liu Q, Singla LD, Zhou H (2012) Vaccines against Toxoplasma gondii: status, challenges and future directions. Hum Vaccin Immunother 8(9):1305\u20131308. https:\/\/doi.org\/10.4161\/hv.21006","journal-title":"Hum Vaccin Immunother"},{"key":"2998_CR29","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.31661\/gmj.v9i0.1708","volume":"9","author":"M Karimi","year":"2020","unstructured":"Karimi M, Tabaei SJS, Ranjbar MM, Fathi F, Jalili A, Zaminet Gh,\u00a0Javadi Mamaghani, A al (2020) Construction of a synthetic gene encoding the multi-epitope of Toxoplasma gondii and demonstration of the relevant recombinant protein production: a vaccine candidate. Galen Med J 9:1708","journal-title":"Galen Medical Journal"},{"key":"2998_CR30","doi-asserted-by":"crossref","unstructured":"Ambroise-Thomas P, Petersen E (2000) Congenital toxoplasmosis: past, present and future. In Congenital toxoplasmosis 1\u20137","DOI":"10.1007\/978-2-8178-0847-5_1"},{"issue":"4","key":"2998_CR31","first-page":"334","volume":"60","author":"SA Chaudhry","year":"2014","unstructured":"Chaudhry SA, Gad N, Koren G (2014) Toxoplasmosis and pregnancy Canadian family physician 60(4):334\u2013336","journal-title":"Toxoplasmosis and pregnancy Canadian family physician"},{"issue":"2","key":"2998_CR32","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4161\/hv.22474","volume":"9","author":"R Verma","year":"2013","unstructured":"Verma R, Khanna P (2013) Development of Toxoplasma gondii vaccine: a global challenge. Hum Vaccin Immunother 9(2):291\u2013293. https:\/\/doi.org\/10.4161\/hv.22474","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"2998_CR33","first-page":"127","volume":"2","author":"G Saadatnia","year":"2017","unstructured":"Saadatnia G (2017) Toxoplasmosis infection in pregnant women. Sarem\u00a0J Med Res\u00a02(2):127\u2013131","journal-title":"Sarem Journal of Medical research"},{"key":"2998_CR34","doi-asserted-by":"crossref","unstructured":"Lee DH, Lee SH, Kim AR, Quan FS (2016) Virus-like nanoparticle vaccine confers protection against Toxoplasma gondii. PloS one 11(8):e0161231","DOI":"10.1371\/journal.pone.0161231"},{"issue":"26","key":"2998_CR35","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1016\/j.vaccine.2014.03.092","volume":"32","author":"K El Bissati","year":"2014","unstructured":"El Bissati K, Zhou Y, Dasgupta D et al (2014) Effectiveness of a novel immunogenic nanoparticle platform for Toxoplasma peptide vaccine in HLA transgenic mice. Vaccine 32(26):3243\u20133248","journal-title":"Vaccine"},{"key":"2998_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.trivac.2015.11.002","volume":"5","author":"Y Gedik","year":"2016","unstructured":"Gedik Y, \u0130z SG, Can H et al (2016) Immunogenic multistage recombinant protein vaccine confers partial protection against experimental toxoplasmosis mimicking natural infection in murine model. Trials in Vaccinology 5:15\u201323","journal-title":"Trials in Vaccinology"},{"key":"2998_CR37","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/1756-3305-7-180","volume":"7","author":"Y Wang","year":"2014","unstructured":"Wang Y, Yin H (2014) Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii. Parasit Vectors 7:180. https:\/\/doi.org\/10.1186\/1756-3305-7-180","journal-title":"Parasit Vectors"},{"issue":"2","key":"2998_CR38","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.exppara.2013.07.013","volume":"135","author":"D Qu","year":"2013","unstructured":"Qu D, Han J, Du A (2013) Enhancement of protective immune response to recombinant Toxoplasma gondii ROP18 antigen by ginsenoside Re. Exp Parasitol 135(2):234\u2013239","journal-title":"Exp Parasitol"},{"issue":"1","key":"2998_CR39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00430-016-0483-9","volume":"206","author":"I Rashid","year":"2017","unstructured":"Rashid I, Moir\u00e9 N, H\u00e9raut B et al (2017) Enhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal route. Med Microbiol Immunol 206(1):53\u201362","journal-title":"Med Microbiol Immunol"},{"issue":"4","key":"2998_CR40","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1128\/CDLI.11.4.704-710.2004","volume":"11","author":"V Martin","year":"2004","unstructured":"Martin V, Supanitsky A, Echeverria PC et al (2004) Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis. Clin Vaccine Immunol 11(4):704\u2013710","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"2998_CR41","first-page":"133","volume":"131","author":"B Dziadek","year":"2012","unstructured":"Dziadek B, Gatkowska J, Grzybowski M et al (2012) Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB\/c mice. Parasitology 131(1):133\u2013138","journal-title":"Parasitology"},{"issue":"5","key":"2998_CR42","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00436-010-1742-0","volume":"106","author":"M Liu","year":"2010","unstructured":"Liu M, Yuan Z, Peng G et al (2010) Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis. Parasitol Res 106(5):1079\u20131084","journal-title":"Parasitol Res"},{"issue":"1","key":"2998_CR43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.exppara.2009.06.002","volume":"123","author":"B Dziadek","year":"2009","unstructured":"Dziadek B, Gatkowska J, Brzostek A et al (2009) Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis. Exp Parasitol 123(1):81\u201389","journal-title":"Exp Parasitol"},{"key":"2998_CR44","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.vetpar.2018.02.043","volume":"254","author":"J Gatkowska","year":"2018","unstructured":"Gatkowska J, Wieczorek M, Dziadek B et al (2018) Assessment of the antigenic and neuroprotective activity of the subunit anti-Toxoplasma vaccine in T. gondii experimentally infected mice. Vet Parasitol 254:82\u201394","journal-title":"Vet Parasitol"},{"issue":"3","key":"2998_CR45","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00436-011-2296-5","volume":"109","author":"W-S Li","year":"2011","unstructured":"Li W-S, Chen Q-X, Ye J-X et al (2011) Comparative evaluation of immunization with recombinant protein and plasmid DNA vaccines of fusion antigen ROP2 and SAG1 from Toxoplasma gondii in mice: cellular and humoral immune responses. Parasitol Res 109(3):637\u2013644","journal-title":"Parasitol Res"},{"issue":"1","key":"2998_CR46","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1590\/s1984-29612017007","volume":"26","author":"DL Zulpo","year":"2017","unstructured":"Zulpo DL, Igarashi M, Sammi AS et al (2017) rROP2 from Toxoplasma gondii as a potential vaccine against oocyst shedding in domestic cats. Rev Bras Parasitol Vet 26(1):67\u201373","journal-title":"Rev Bras Parasitol Vet"},{"issue":"9","key":"2998_CR47","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.1128\/IAI.68.9.4948-4953.2000","volume":"68","author":"M Haumont","year":"2000","unstructured":"Haumont M, Delhaye L, Garcia L et al (2000) Protective immunity against congenital toxoplasmosis with recombinant SAG1 protein in a guinea pig model. Infect Immun 68(9):4948\u20134953","journal-title":"Infect Immun"},{"issue":"41","key":"2998_CR48","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1016\/j.vaccine.2013.07.058","volume":"31","author":"B Zheng","year":"2013","unstructured":"Zheng B, Lu S, Tong Q et al (2013) The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma gondii is a novel vaccine candidate against toxoplasmosis in mice. Vaccine 31(41):4578\u20134584","journal-title":"Vaccine"},{"issue":"3","key":"2998_CR49","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.exppara.2012.01.001","volume":"130","author":"X Huang","year":"2012","unstructured":"Huang X, Li J, Zhang G et al (2012) Toxoplasma gondii: protective immunity against toxoplasmosis with recombinant actin depolymerizing factor protein in BALB\/c mice. Exp Parasitol 130(3):218\u2013222","journal-title":"Exp Parasitol"},{"issue":"21","key":"2998_CR50","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1016\/j.vaccine.2007.02.057","volume":"25","author":"M Golkar","year":"2007","unstructured":"Golkar M, Shokrgozar M-A, Rafati S et al (2007) Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice. Vaccine 25(21):4301\u20134311","journal-title":"Vaccine"},{"key":"2998_CR51","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3389\/fmicb.2016.00609","volume":"7","author":"XT Ching","year":"2016","unstructured":"Ching XT, Fong MY, Lau YL (2016) Evaluation of immunoprotection conferred by the subunit vaccines of GRA2 and GRA5 against acute toxoplasmosis in BALB\/c mice. Front Microbiol 7:609","journal-title":"Front Microbiol"},{"issue":"1","key":"2998_CR52","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s004360050198","volume":"83","author":"A Lunden","year":"1996","unstructured":"Lunden A, Parmley S, Bengtsson KL, Araujo FJ (1996) Use of a recombinant antigen, SAG2, expressed as a glutathione-S-transferase fusion protein to immunize mice against Toxoplasma gondii. Parasitol Res 83(1):6\u20139","journal-title":"Parasitol Res"},{"key":"2998_CR53","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3389\/fcimb.2017.00142","volume":"7","author":"P Czarnewski","year":"2017","unstructured":"Czarnewski P, Ara\u00fajo ECB, Oliveira MC et al (2017) Recombinant TgHSP70 immunization protects against Toxoplasma gondii brain cyst formation by enhancing inducible nitric oxide expression. Front Cell Infect Microbiol 7:142. https:\/\/doi.org\/10.3389\/fcimb.2017.00142","journal-title":"Front Cell Infect Microbiol"},{"key":"2998_CR54","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/1756-3305-4-213","volume":"4","author":"XM Sun","year":"2011","unstructured":"Sun XM, Zou J, A AE et al (2011) DNA vaccination with a gene encoding Toxoplasma gondii GRA6 induces partial protection against toxoplasmosis in BALB\/c mice. Parasit Vectors 4:213. https:\/\/doi.org\/10.1186\/1756-3305-4-213","journal-title":"Parasit Vectors"},{"issue":"1","key":"2998_CR55","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1086\/315186","volume":"181","author":"C Angus","year":"2000","unstructured":"Angus C, Klivington-Evans D, Dubey J, Kovacs JA (2000) Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents. J Infect Dis 181(1):317\u2013324","journal-title":"J Infect Dis"},{"issue":"1","key":"2998_CR56","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1128\/CVI.00312-10","volume":"18","author":"ZG Yuan","year":"2011","unstructured":"Yuan ZG, Zhang XX, He XH et al (2011) Protective immunity induced by Toxoplasma gondii rhoptry protein 16 against toxoplasmosis in mice. Clin Vaccine Immunol 18(1):119\u2013124","journal-title":"Clin Vaccine Immunol"},{"key":"2998_CR57","doi-asserted-by":"crossref","unstructured":"Pagheh AS, Sarvi S, Gholami S et al (2019) Protective efficacy induced by DNA prime and recombinant protein boost vaccination with Toxoplasma gondii GRA14 in mice.\u00a0Microb Pathog\u00a0134:103601","DOI":"10.1016\/j.micpath.2019.103601"},{"key":"2998_CR58","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.imlet.2017.03.006","volume":"185","author":"E Ahmadpour","year":"2017","unstructured":"Ahmadpour E, Sarvi S, Soteh MBH et al (2017) Enhancing immune responses to a DNA vaccine encoding Toxoplasma gondii GRA14 by calcium phosphate nanoparticles as an adjuvant. Immunol Lett 185:40\u201347","journal-title":"Immunol Lett"},{"key":"2998_CR59","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.actatropica.2017.09.007","volume":"176","author":"WB Yang","year":"2017","unstructured":"Yang WB, Zhou DH, Zou Y et al (2017) Vaccination with a DNA vaccine encoding Toxoplasma gondii ROP54 induces protective immunity against toxoplasmosis in mice. Acta Trop 176:427\u2013432","journal-title":"Acta Trop"},{"key":"2998_CR60","doi-asserted-by":"crossref","unstructured":"Chen K, Wang JL, Huang SY et al (2017) Immune responses and protection after DNA vaccination against Toxoplasma gondii calcium-dependent protein kinase 2 (TgCDPK2). Parasite 24","DOI":"10.1051\/parasite\/2017045"},{"key":"2998_CR61","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.biologicals.2019.10.002","volume":"62","author":"S Maraghi","year":"2019","unstructured":"Maraghi S, Ghadiri AA, Tavalla M et al (2019) Evaluation of immunogenicity and protective effect of DNA vaccine encoding surface antigen1 (SAG1) of Toxoplasma gondii and TLR-5 ligand as a genetic adjuvant against acute toxoplasmosis in BALB\/c mice. Biologicals 62:39\u201349","journal-title":"Biologicals"},{"issue":"1","key":"2998_CR62","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3103\/S0891416819010099","volume":"34","author":"H Sobati","year":"2019","unstructured":"Sobati H, Dalimi A, Kazemi B, Ghaffarifar F (2019) Evaluation of anti-Toxoplasma gondii immune responses in BALB\/c mice induced by DNA vaccines encoding surface antigen 1 (SAG1) and 3 (SAG3). Mol Genet Microbiol Virol 34(1):59\u201366","journal-title":"Mol Genet Microbiol Virol"},{"key":"2998_CR63","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3389\/fmicb.2019.00734","volume":"10","author":"B Zheng","year":"2019","unstructured":"Zheng B, Ding J, Lou D et al (2019) The virulence-related MYR1 protein of Toxoplasma gondii as a novel DNA vaccine against toxoplasmosis in mice. Front Microbiol 10:734","journal-title":"Front Microbiol"},{"key":"2998_CR64","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.exppara.2018.04.003","volume":"188","author":"Y Chen","year":"2018","unstructured":"Chen Y, Yu M, Hemandez JA et al (2018) Immuno-efficacy of DNA vaccines encoding PLP1 and ROP18 against experimental Toxoplasma gondii infection in mice. Exp Parasitol 188:73\u201378","journal-title":"Exp Parasitol"},{"issue":"6","key":"2998_CR65","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.4269\/ajtmh.16-0548","volume":"96","author":"XT Ching","year":"2017","unstructured":"Ching XT, Fong MY, Lau YL (2017) Evaluation of the protective effect of deoxyribonucleic acid vaccines encoding granule antigen 2 and 5 against acute Toxoplasmosis in BALB\/c Mice. Am J Trop Med Hyg 96(6):1441","journal-title":"Am J Trop Med Hyg"},{"key":"2998_CR66","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.exppara.2017.06.002","volume":"179","author":"WN Zhu","year":"2017","unstructured":"Zhu WN, Wang JL, Chen K et al (2017) Evaluation of protective immunity induced by DNA vaccination with genes encoding Toxoplasma gondii GRA17 and GRA23 against acute toxoplasmosis in mice. Exp Parasitol 179:20\u201327","journal-title":"Exp Parasitol"},{"issue":"1","key":"2998_CR67","first-page":"2","volume":"10","author":"H Vazini","year":"2018","unstructured":"Vazini H, Ghafarifar F, Sharifi Z, Dalimi A (2018) Evaluation of immune responses induced by GRA7 and ROP2 genes by DNA vaccine cocktails against acute toxoplasmosis in BALB\/c mice. Avicenna J Med Biotechnol 10(1):2","journal-title":"Avicenna J Med Biotechnol"},{"issue":"27","key":"2998_CR68","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1016\/j.vaccine.2018.05.072","volume":"36","author":"LJ Wang","year":"2018","unstructured":"Wang LJ, Xiao T, Xu C et al (2018) Protective immune response against Toxoplasma gondii elicited by a novel yeast-based vaccine with microneme protein 16. Vaccine 36(27):3943\u20133948. https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.072","journal-title":"Vaccine"},{"key":"2998_CR69","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3389\/fmicb.2018.00909","volume":"9","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Li Y, Wang M et al (2018) Immune protection of rhoptry protein 21 (ROP21) of Toxoplasma gondii as a DNA vaccine against toxoplasmosis. Front Microbiol 9:909","journal-title":"Front Microbiol"},{"key":"2998_CR70","doi-asserted-by":"publisher","first-page":"1295038","DOI":"10.1155\/2017\/1295038","volume":"2017","author":"LY Hu","year":"2017","unstructured":"Hu LY, Zhang NZ, Zhang FK et al (2017) Resistance to chronic Toxoplasma gondii Infection Induced by a DNA vaccine expressing GRA16. Biomed Res Int 2017:1295038. https:\/\/doi.org\/10.1155\/2017\/1295038","journal-title":"Biomed Res Int"},{"issue":"1","key":"2998_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-016-2104-z","volume":"17","author":"Y Han","year":"2017","unstructured":"Han Y, Zhou A, Lu G et al (2017) Protection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB\/c mice. BMC Infect Dis 17(1):1\u20139","journal-title":"BMC Infect Dis"},{"key":"2998_CR72","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.vetpar.2018.06.016","volume":"260","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Li Y, Liang Y et al (2018) Molecular characterization and protective immunity of rhoptry protein 35 (ROP35) of Toxoplasma gondii as a DNA Vaccine. Vet Parasitol 260:12\u201321","journal-title":"Vet Parasitol"},{"issue":"4","key":"2998_CR73","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3347\/kjp.2018.56.4.325","volume":"56","author":"JQ Chu","year":"2018","unstructured":"Chu JQ, Huang S, Ye W et al (2018) Evaluation of protective immune response induced by a DNA vaccine encoding GRA8 against acute toxoplasmosis in a murine model. Korean J Parasitol 56(4):325","journal-title":"Korean J Parasitol"},{"key":"2998_CR74","doi-asserted-by":"crossref","unstructured":"Zhou J, Wang L, Lu G et al (2016) Epitope analysis and protection by a ROP19 DNA vaccine against Toxoplasma gondii. Parasite 23","DOI":"10.1051\/parasite\/2016017"},{"key":"2998_CR75","doi-asserted-by":"crossref","unstructured":"Xu XP, Liu WG, Xu QM et al (2019) Evaluation of immune protection against Toxoplasma gondii infection in mice induced by a multi-antigenic DNA vaccine containing TgGRA24, TgGRA25 and TgMIC6. Parasite 26","DOI":"10.1051\/parasite\/2019050"},{"issue":"1","key":"2998_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-014-0706-x","volume":"14","author":"G Lu","year":"2014","unstructured":"Lu G, Zhou A, Meng M et al (2014) Alpha-galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii. BMC Infect Dis 14(1):1\u20139","journal-title":"BMC Infect Dis"},{"issue":"23","key":"2998_CR77","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1016\/S0264-410X(00)00035-9","volume":"18","author":"B Desolme","year":"2000","unstructured":"Desolme B, M\u00e9v\u00e9lec MN, Buzoni-Gatel D, Bout D (2000) Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene. Vaccine 18(23):2512\u20132521","journal-title":"Vaccine"},{"issue":"5","key":"2998_CR78","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2217\/fmb-2016-0146","volume":"12","author":"C Ducournau","year":"2017","unstructured":"Ducournau C, Nguyen TT, Carpentier R et al (2017) Synthetic parasites: a successful mucosal nanoparticle vaccine against Toxoplasma congenital infection in mice. Future Microbiol 12(5):393\u2013405","journal-title":"Future Microbiol"},{"key":"2998_CR79","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.smallrumres.2017.03.008","volume":"150","author":"G Oledzka","year":"2017","unstructured":"Oledzka G, Bo L, Hiszczynska-Sawicka E et al (2017) Toxoplasma gondii: immunological response of sheep to injections of recombinant SAG1, SAG2, GRA1 proteins coupled to the non-toxic microparticle muramyl dipeptide. Small Rumin Res 150:111\u2013117","journal-title":"Small Rumin Res"},{"issue":"4","key":"2998_CR80","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.parint.2007.04.003","volume":"56","author":"H Wang","year":"2007","unstructured":"Wang H, Liu Q, Liu K et al (2007) Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii. Parasitol Int 56(4):263\u2013268","journal-title":"Parasitol Int"},{"issue":"1","key":"2998_CR81","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00436-016-5298-5","volume":"116","author":"H Nabi","year":"2017","unstructured":"Nabi H, Rashid I, Ahmad N et al (2017) Induction of specific humoral immune response in mice immunized with ROP18 nanospheres from Toxoplasma gondii. Parasitol Res 116(1):359\u2013370","journal-title":"Parasitol Res"},{"key":"2998_CR82","doi-asserted-by":"crossref","unstructured":"Karthik L, Kumar G, Keswani T et al (2014) Protease inhibitors from marine actinobacteria as a potential source for antimalarial compound. PloS one 9(3):e90972","DOI":"10.1371\/journal.pone.0090972"},{"issue":"8","key":"2998_CR83","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.vaccine.2018.12.044","volume":"37","author":"D Zhang","year":"2019","unstructured":"Zhang D, Jiang N, Chen Q (2019) Vaccination with recombinant adenoviruses expressing Toxoplasma gondii MIC3, ROP9, and SAG2 provide protective immunity against acute toxoplasmosis in mice. Vaccine 37(8):1118\u20131125","journal-title":"Vaccine"},{"key":"2998_CR84","doi-asserted-by":"crossref","unstructured":"Allahyari M, Mohabati R, Vatanara A, Golkar M (2020) In-vitro and in-vivo comparison of rSAG1-loaded PLGA prepared by encapsulation and adsorption methods as an efficient vaccine against Toxoplasma gondii. J Drug Deliv Sci Technol 55:101327","DOI":"10.1016\/j.jddst.2019.101327"},{"issue":"38","key":"2998_CR85","doi-asserted-by":"publisher","first-page":"5692","DOI":"10.1016\/j.vaccine.2018.08.016","volume":"36","author":"SH Lee","year":"2018","unstructured":"Lee SH, Kang HJ, Lee DH et al (2018) Virus-like particle vaccines expressing Toxoplasma gondii rhoptry protein 18 and microneme protein 8 provide enhanced protection. Vaccine 36(38):5692\u20135700","journal-title":"Vaccine"},{"issue":"sup2","key":"2998_CR86","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1080\/21691401.2018.1478421","volume":"46","author":"H Naeem","year":"2018","unstructured":"Naeem H, Sana M, Islam S et al (2018) Induction of Th1 type-oriented humoral response through intranasal immunization of mice with SAG1-Toxoplasma gondii polymeric nanospheres. Artificial Cells, Nanomedicine, and Biotechnology 46(sup2):1025\u20131034","journal-title":"Artificial Cells, Nanomedicine, and Biotechnology"},{"issue":"4","key":"2998_CR87","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/biomedicines8040091","volume":"8","author":"WH Choi","year":"2020","unstructured":"Choi WH, Park JS (2020) Immunogenicity and protective effect of a virus-like particle containing the SAG1 antigen of Toxoplasma gondii as a potential vaccine candidate for toxoplasmosis. Biomedicines 8(4):91","journal-title":"Biomedicines"},{"key":"2998_CR88","doi-asserted-by":"crossref","unstructured":"Kim MJ, Lee SH, Kang HJ et al (2020) Virus-like particle vaccine displaying Toxoplasma gondii apical membrane antigen 1 induces protection against T. gondii ME49 infection in mice.\u00a0Microb Pathog\u00a0142:104090","DOI":"10.1016\/j.micpath.2020.104090"},{"key":"2998_CR89","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1590\/S0100-879X2012007500142","volume":"45","author":"IP Nascimento","year":"2012","unstructured":"Nascimento IP, Leite L (2012) Recombinant vaccines and the development of new vaccine strategies. Braz J Med Biol Res 45:1102\u20131111","journal-title":"Braz J Med Biol Res"},{"key":"2998_CR90","doi-asserted-by":"crossref","unstructured":"Aghamolaei S, Kazemi B, Bandehpour M et al (2020) Design and expression of polytopic construct of cathepsin-L1, SAP-2 and FhTP16. 5 proteins of Fasciola hepatica. J Helminthol 94","DOI":"10.1017\/S0022149X20000140"},{"key":"2998_CR91","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.micres.2015.11.006","volume":"183","author":"Z Arab-Mazar","year":"2016","unstructured":"Arab-Mazar Z, Fallahi S, Koochaki A et al (2016) Immunodiagnosis and molecular validation of Toxoplasma gondii-recombinant dense granular (GRA) 7 protein for the detection of toxoplasmosis in patients with cancer. Microbiol Res 183:53\u201359","journal-title":"Microbiol Res"},{"issue":"5","key":"2998_CR92","first-page":"331","volume":"8","author":"Z Arab-Mazar","year":"2016","unstructured":"Arab-Mazar Z, Fallahi S, Koochaki A et al (2016) Cloning, expression and immunoreactivity of recombinant Toxoplasma gondii GRA5 protein.\u00a0Iran J Microbiol\u00a08(5):331","journal-title":"Iranian journal of microbiology"},{"issue":"4","key":"2998_CR93","first-page":"114","volume":"2","author":"Z Arab-Mazar","year":"2014","unstructured":"Arab-Mazar Z, Seyyed-Tabaei SJ, Mirahmadi H (2014) Cloning of dense granular (GRA) 7 gene of Toxoplasma gondii into pTZ57RT vectors for sub-cloning in prokaryotic and eukaryotic plasmids. Novelty in Biomedicine 2(4):114\u2013119","journal-title":"Novelty in Biomedicine"},{"issue":"1","key":"2998_CR94","doi-asserted-by":"publisher","first-page":"4","DOI":"10.7774\/cevr.2019.8.1.4","volume":"8","author":"M Foroutan","year":"2019","unstructured":"Foroutan M, Ghaffarifar F, Sharifi Z et al (2019) Rhoptry antigens as Toxoplasma gondii vaccine target.\u00a0Clin Exp Vaccine Res\u00a08(1):4\u201326. https:\/\/doi.org\/10.7774\/cevr.2019.8.1.4","journal-title":"Clinical and experimental vaccine research"},{"issue":"2","key":"2998_CR95","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00705-010-0863-1","volume":"156","author":"PMH Heegaard","year":"2011","unstructured":"Heegaard PMH, Dedieu L, Johnson N et al (2011) Adjuvants and delivery systems in veterinary vaccinology: current state and future developments. Adv Virol 156(2):183\u2013202. https:\/\/doi.org\/10.1007\/s00705-010-0863-1","journal-title":"Adv Virol"},{"issue":"4","key":"2998_CR96","first-page":"17","volume":"7","author":"N Jalallou","year":"2012","unstructured":"Jalallou N, Bandehpour M, Khazan H et al (2012) Evaluation of recombinant SAG1 protein for detection of Toxoplasma gondii specific immunoglobulin M by ELISA test. Iran J Parasitol 7(4):17\u201321","journal-title":"Iran J Parasitol"},{"issue":"2","key":"2998_CR97","doi-asserted-by":"publisher","first-page":"75","DOI":"10.29252\/JABR.05.02.07","volume":"5","author":"M Ashrafi","year":"2018","unstructured":"Ashrafi M, Sobati H, Tabaei SJ (2018) Construction and sequencing of dense granular14 (GRA14) gene of Toxoplasma gondii (RH) in expression prokaryotic plasmid PET32a: a preliminary study in vaccine production. J Appl Biotechnol Reps 5(2):75\u201380","journal-title":"J Appl Biotechnol Reps"},{"issue":"1","key":"2998_CR98","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13071-019-3341-y","volume":"12","author":"K Yin","year":"2019","unstructured":"Yin K, Zhao G, Xu C et al (2019) Prediction of Toxoplasma gondii virulence factor ROP18 competitive inhibitors by virtual screening. Parasit Vectors 12(1):98. https:\/\/doi.org\/10.1186\/s13071-019-3341-y","journal-title":"Parasit Vectors"},{"key":"2998_CR99","doi-asserted-by":"crossref","unstructured":"El Hajj H, Lebrun M, Arold ST et al (2007) ROP18 is a rhoptry kinase controlling the intracellular proliferation of Toxoplasma gondii. PLoS Pathog 3(2)","DOI":"10.1371\/journal.ppat.0030014"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-022-02998-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-022-02998-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-022-02998-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T07:07:21Z","timestamp":1744182441000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-022-02998-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,8]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["2998"],"URL":"https:\/\/doi.org\/10.1007\/s11845-022-02998-9","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,8]]},"assertion":[{"value":"10 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was approved by the Kermanshah University of Medical Sciences Ethics Committee [IR.KUMS.REC.1400.070].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}